Oat attenuation of hyperglycemia-induced retinal oxidative stress and NF- B activation in streptozotocin-induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Al Malki, Abdulrahman L ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; MALE; NONHUMAN; OAT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 84873375027     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/983923     Document Type: Article

References (58)

1. Sharma S., Oliver-Fernandez A., Liu W., Buchholz P., Walt J., The impact of diabetic retinopathy on health-related quality of life. Current Opinion in Ophthalmology 2005 16 3 155 159 2-s2.0-18844433338 10.1097/01.icu.0000161227. 21797.3d (Pubitemid 40694973)
2. Frank R. N., Diabetic retinopathy. The New England Journal of Medicine 2004 350 1 48 58 10.1056/NEJMra021678 (Pubitemid 38032183)
3. Mahmood D., Singh B. K., Akhtar M., Diabetic neuropathy: therapies on the horizon. Journal of Pharmacy and Pharmacology 2009 61 9 1137 1145 2-s2.0-70350501530 10.1211/jpp/61.09.0002
4. Robison W. G. Jr., Kador P. F., Kinoshita J. H., Early retinal microangiopathy: prevention with aldose reductase inhibitors. Diabetic Medicine 1985 2 3 196 199 2-s2.0-0022256975 (Pubitemid 15002150)
5. Harhaj N. S., Antonetti D. A., Regulation of tight junctions and loss of barrier function in pathophysiology. International Journal of Biochemistry and Cell Biology 2004 36 7 1206 1237 2-s2.0-1942502810 10.1016/j.biocel.2003.08.007 (Pubitemid 38519069)
6. Bhaskar J. J., Shobha M. S., Sambaiah K., Salimath P. V., Beneficial effects of banana (Musa sp. var. elakki bale) flower and pseudostem on hyperglycemia and advanced glycation end-products (AGEs) in streptozotocin- induced diabetic rats. Journal of Physiology and Biochemistry 2011 67 3 415 425 2-s2.0-79953650083 10.1007/s13105-011-0091-5
7. Frank R. N., On the pathogenesis of diabetic retinopathy: a 1990 update. Ophthalmology 1991 98 5 586 593
8. Kern T. S., Tang J., Mizutani M., Kowluru R. A., Nagaraj R. H., Romeo G., Podesta F., Lorenzi M., Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Investigative Ophthalmology and Visual Science 2000 41 12 3972 3978 2-s2.0-0033753702
9. Joussen A. M., Poulaki V., Le M. L., A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal 2004 18 12 1450 1452 (Pubitemid 39561611)
10. Nakagawa T., Yokozawa T., Terasawa K., Nakanishi K., Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy. Journal of Pharmacy and Pharmacology 2003 55 2 219 227 2-s2.0-0037331517 10.1211/002235702450 (Pubitemid 36277760)
11. Hammes H. P., Brownlee M., Lin J., Schleicher E., Bretzel R. G., Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N(ε)-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 1999 42 5 603 607 2-s2.0-0032968131 10.1007/s001250051201 (Pubitemid 29196012)
12. Robison W. G. Jr., Nagata M., Tillis T. N., Laver N., Kinoshita J. H., Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Investigative Ophthalmology and Visual Science 1989 30 11 2293 2299 2-s2.0-0024389613 (Pubitemid 20004227)
13. Troudi A., Ben Amara I., Soudani N., Samet A. M., Zeghal N., Oxidative stress induced by gibberellic acid on kidney tissue of female rats and their progeny: biochemical and histopathological studies. Journal of Physiology and Biochemistry 2011 67 3 307 316 10.1007/s13105-011-0076-4
14. Murata T., Nagai R., Ishibashi T., Inomata H., Ikeda K., Horiuchi S., The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 1997 40 7 764 769 2-s2.0-0030805762 10.1007/s001250050747 (Pubitemid 27306953)
15. Hammes H. P., Wellensiek B., Klöting I., Sickel E., Bretzel R. G., Brownlee M., The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 1998 41 2 165 170 2-s2.0-0031910005 10.1007/s001250050885 (Pubitemid 28088392)
16. Sayed A. A. R., Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Europian Reviews for Medical and Pharmacological Science 2012 16 6 808 815
17. Aziz M., Motawi T., Rezq A., Effects of a water-soluble curcumin protein conjugate versus pure curcumin in a diabetic model of erectile dysfunction. Journal of Sexual Medicine 2012 9 7 1815 1833
18. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
19. Würsch P., Pi-Sunyer F. X., The role of viscous soluble fiber in the metabolic control of diabetes: a review with special emphasis on cereals rich in β -glucan. Diabetes Care 1997 20 11 1774 1780 2-s2.0-1842295124
20. Vuksan V., Sievenpiper J. L., Xu Z., Wong E. Y. Y., Jenkins A. L., Beljan-Zdravkovic U., Leiter L. A., Josse R. G., Stavro M. P., Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus. Journal of the American College of Nutrition 2001 20 5 370S 380S 2-s2.0-0034778805 (Pubitemid 32951814)
21. Jenkins D. J. A., Wolever T. M. S., Leeds A. R., Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. British Medical Journal 1978 1 6124 1392 1394 2-s2.0-0018142395 (Pubitemid 8334007)
22. Hallfrisch J., Behall K. M., Mechanisms of the effects of grains on insulin and glucose responses. Journal of the American College of Nutrition 2000 19 supplement 3 S320 S325 2-s2.0-0034044262
23. Wood P. J., Braaten J. T., Scott F. W., Riedel K. D., Wolynetz M. S., Collins M. W., Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. British Journal of Nutrition 1994 72 5 731 743 2-s2.0-0028073116 10.1079/BJN19940075 (Pubitemid 24362449)
24. Tapola N., Karvonen H., Niskanen L., Mikola M., Sarkkinen E., Glycemic responses of oat bran products in type 2 diabetic patients. Nutrition, Metabolism and Cardiovascular Diseases 2005 15 4 255 261 2-s2.0-23944514875 10.1016/j.numecd.2004.09.003 (Pubitemid 41190982)
25. Panahi S., Ezatagha A., Temelli F., Vasanthan T., Vuksan V., β -glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. Journal of the American College of Nutrition 2007 26 6 639 644 2-s2.0-40749093273
26. Moselhy S. S., Al-Malki A. L., Kumosani T. A., Jalal J.A., Modulatory effect of cod liver oil on bone mineralization in overiectomized female Sprague Dawley rats. Toxicology and Industrial Health 2012 28 5 387 392
27. Sayed A. A. R., Thymoquinone protects renal tubular cells against tubular injury. Cell Biochemistry and Function 2008 26 3 374 380 2-s2.0-42949125024 10.1002/cbf.1454 (Pubitemid 351613180)
28. Moron M. S., Depierre J. W., Mannervik B., Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 1979 582 1 67 78 2-s2.0-0018327389 (Pubitemid 9065588)
29. Mekheimer R. A., Sayed A. A. R., Ahmed E., Novel 1, 2, 4-triazolo[1, 5-a]pyridines and their fused ring systems attenuate oxidative stress and prolong lifespan of Caenorhabiditis elegans. Journal of Medicinal Chemistry 2012 55 9 4169 4177
30. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
31. Sayed A. A. R., Ferulsinaic acid attenuation of advanced glycation end products extends the lifespan of Caenorhabditis elegans. Journal of Pharmacy and Pharmacology 2011 63 3 423 428 10.1111/j.2042-7158.2010.01222.x
32. Sayed A. A. R., Khalifa M., Abdelatif F. F., Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats. Journal of Physiology and Biochemistry 2012 68 2 263 269
33. Nishikimi M., Rao N. A., Yagi K., The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochemical and Biophysical Research Communications 1972 46 2 849 854 2-s2.0-0015530358
34. Sayed A. A. R., El-Shaieb K., Mourad A., Life Span Extension of Caenorhabditis elegans by Novel pyrido perimidine drevative. Archivs of Pharmacal Research 2012 35 1 69 76
35. Schlotterer A., Kukudov G., Bozorgmehr F., Hutter H., Du X., Oikonomou D., Ibrahim Y., Pfisterer F., Rabbani N., Thornalley P., Sayed A., Fleming T., Humpert P., Schwenger V., Zeier M., Hamann A., Stern D., Brownlee M., Bierhaus A., Nawroth P., Morcos M., C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 2009 58 11 2450 2456 2-s2.0-70350365865 10.2337/db09-0567
36. Morcos M., Schlotterer A., Sayed A. A. R., Kukudov G., Oikomonou D., Ibrahim Y., Pfisterer F., Schneider J., Bozorgmehr F., Rudofsky G., Schwenger V., Kientsch-Engels R., Hamann A., Zeier M., Dugi K., Yard B., Humpert P. M., van der Woude F., Nawroth P. P., Bierhaus A., Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. Hormone and Metabolic Research 2008 40 11 752 759 2-s2.0-59849100342
37. de Laurentiis A., Fernandez-Solari J., Mohn C., Burdet B., Zorrilla Zubilete M. A., Rettori V., The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide. Journal of Neuroimmunology 2010 221 1-2 32 41 2-s2.0-77951239227 10.1016/j.jneuroim.2010.02.006
38. Sayed A. A. R., Morcos M., Thymoquinone decreases AGE-induced NF- B activation in proximal tubular epithelial cells. Phytotherapy Research 2007 21 9 898 899 2-s2.0-34548619335 10.1002/ptr.2177 (Pubitemid 47401863)
39. Morcos M., Sayed A. A. R., Bierhaus A., Yard B., Waldherr R., Merz W., Kloeting I., Schleicher E., Mentz S., Abd el Baki R. F., Tritschler H., Kasper M., Schwenger V., Hamann A., Dugi K. A., Schmidt A. M., Stern D., Ziegler R., Haering H. U., Andrassy M., Van der Woude F., Nawroth P. P., Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002 51 12 3532 3544 2-s2.0-0036895708 (Pubitemid 35403461)
40. Feit-Leichman R. A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T. S., Chen D. F., Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Investigative Ophthalmology and Visual Science 2005 46 11 4281 4287 2-s2.0-33644689817 10.1167/iovs.04-1361 (Pubitemid 44264633)
41. Salido E. M., de Zavalía N., Schreier L., de Laurentiis A., Retinal changes in an experimental model of early type 2 diabetes in rats characterized by non-fasting hyperglycemia. Experimental Neurology 2012 236 151 160 10.1016/j.expneurol.2012.04.010
42. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., Brownlee M., Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. Journal of Clinical Investigation 2003 112 7 1049 1057 2-s2.0-0242285699 10.1172/JCI200318127 (Pubitemid 38056320)
43. Stern D., Yan S. D., Yan S. F., Schmidt A. M., Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Advanced Drug Delivery Reviews 2002 54 12 1615 1625 2-s2.0-0037038819 10.1016/S0169-409X(02)00160-6 (Pubitemid 35346835)
44. Hammes H. P., Alt A., Niwa T., Clausen J. T., Bretzel R. G., Brownlee M., Schleicher E. D., Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 1999 42 6 728 736 2-s2.0-0033028542 10.1007/s001250051221 (Pubitemid 29265591)
45. Quehenberger P., Bierhaus A., Fasching P., Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells. Diabetes 2000 49 9 1561 1570 10.2337/diabetes.49.9.1561
46. Siervo M., Tomatis V., Stephan B. C. M., Feelisch M., Bluck L. J. C., VEGF is indirectly associated with NO production and acutely increases in response to hyperglycaemia. European Journal of Clinical Investigation 2012 42 9 967 973 10.1111/j.1365-2362.2012.02684.x
47. Malecki M. T., Osmenda G., Walus-Miarka M., Skupien J., Cyganek K., Mirkiewicz-Sieradzka B., Damek-Guzik T. A., Guzik T. J., Sieradzki J., Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. European Journal of Clinical Investigation 2008 38 12 925 930 2-s2.0-56649091048 10.1111/j.1365-2362.2008. 02051.x
48. Cao Y., Cao R., Angiogenesis inhibited by drinking tea. Nature 1999 398 6726 381 2-s2.0-0033118504 10.1038/18793 (Pubitemid 29180360)
49. Rodriguez S. K., Guo W., Liu L., Band M. A., Paulson E. K., Meydani M., Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. International Journal of Cancer 2006 118 7 1635 1644 2-s2.0-33644854366 10.1002/ijc.21545 (Pubitemid 43376426)
50. Chen H. S., Wu T. E., Lin L. C. Hsiaoand S.H., Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes. European Journal of Clinical Investigation 2012 42 4 447 454 10.1111/j.1365-2362.2011.02616.x
51. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
52. Lechleitner M., Koch T., Herold M., Dzien A., Hoppichler F., Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. Journal of Internal Medicine 2000 248 1 67 76 2-s2.0-0033941219 10.1046/j.1365-2796. 2000.00705.x (Pubitemid 30470006)
53. Ahmed A. A., Hegazy M. E. F., Zellagui A., Rhouati S., Mohamed T. A., Sayed A. A., Abdella M. A., Ohta S., Hirata T., Ferulsinaic acid, a sesquiterpene coumarin with a rare carbon skeleton from Ferula species. Phytochemistry 2007 68 5 680 686 2-s2.0-33847036351 10.1016/j.phytochem.2006.12. 011 (Pubitemid 46273486)
54. Al-Malki A. L., Moselhy S. S., The protective effect of epicatchin against oxidative stress and nephrotoxicity in rats induced by cyclosporine. Human and Experimental Toxicology 2011 30 2 145 151 2-s2.0-79551505514 10.1177/0960327110369820
55. Sayed A. A. R., Ferulsinaic acid attenuation of diabetic nephropathy. European Journal of Clinical Investigation 2013 43 1 56 63 10. 1111/eci.12015
56. Sayed A. A. R., Ferulsinaic AcidModulates SOD, GSH and Antioxidant Enzymes in diabetic kidney. Evidence-Based Complementary and Alternative Medicine 2012 2012 580104 10. 1155/2012/580104
57. Motawi T., Abdel Aziz M. T., Rezq A., Effects of a water-soluble curcumin protein conjugate versus pure curcumin in a diabetic model of erectile dysfunction. The Journal of Sexual Medicine 2012 9 7 1815 1833 10.1111/j.1743-6109.2012.02741.x
58. Abdel Aziz M. T., El-Asmar M. F., El-Ibrashy I. N., Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short term study). Diabetology & Metabolic Syndrome 2012 4 1 30 10.1186/1758-5996-4-30